Oesophageal Cancer Trial, Recruiting NCT06618742 Sponsor: Laura Boer Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT06618742
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older at the time of signing consent
  • You have been diagnosed with esophageal or gastroesophageal (where the esophagus meets the stomach) cancer, confirmed by a tissue sample
  • You are receiving care focused on managing symptoms and quality of life (palliative care), whether or not you are receiving or plan to receive chemotherapy
  • You have difficulty swallowing, specifically meaning you can only manage soft or semi-solid foods at a minimum
  • You are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

  • Your swallowing difficulty is caused by something other than your cancer
  • The thin, flexible camera (endoscope) used in this trial cannot pass through your esophagus
  • You have serious other health conditions that make it unsafe to undergo an endoscopy (a camera examination of the digestive tract)
  • You have a blood clotting problem that has not been treated or corrected
  • You have previously had surgery to remove part of the lower esophagus
  • You have a history of enlarged, fragile veins in your esophagus (varices)
  • Your expected survival is less than 6 weeks
  • You have previously had radiotherapy treatment directed at your esophageal cancer
  • Your cancer has grown into nearby structures in a specific advanced way (confirm with trial site)
  • You are not able to make your own decisions about participating
  • You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0887550224

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Laura Boer
Registry
ClinicalTrials.gov
Start date
24 June 2024
Est. completion
31 July 2025

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Primary outcome safety; primary outcome efficacy; primary outcome feasibility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov